Globus Medical Reports Second Quarter 2015 Results
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2015.
* Worldwide sales increased 17.6% to $133.6 million, or 19.1% on a constant currency basis
* Second quarter net income increased 16.5% to $24.1 million
* Fully diluted earnings per share (EPS) were $0.25
* Non-GAAP Adjusted EBITDA was 35.0% of sales
* Company increases 2015 guidance for sales to $524 million and EPS to $1.04
Help employers find you! Check out all the jobs and post your resume.
* Worldwide sales increased 17.6% to $133.6 million, or 19.1% on a constant currency basis
* Second quarter net income increased 16.5% to $24.1 million
* Fully diluted earnings per share (EPS) were $0.25
* Non-GAAP Adjusted EBITDA was 35.0% of sales
* Company increases 2015 guidance for sales to $524 million and EPS to $1.04
Help employers find you! Check out all the jobs and post your resume.